All In Biotech

Drug Trial Radar · NCT03291067

MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women

A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women

Last checked: Nov 20, 2026Latest source record: Jan 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 375 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

375

Actual

Start

Oct 9, 2017

Primary completion

Oct 19, 2018

Study completion Nov 9, 2018

Sponsor

Lead sponsor
Tanabe Pharma America, Inc.Industry
Sponsor type
Industry
First posted
Sep 25, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the efficacy and safety of MT-8554 for treatment of vasomotor symptoms (VMS) associated with menopause.

Conditions

  • Menopause Hot Flashes

Interventions

  • MT-8554 1mgDrug

    MT-8554 1mg QD, oral, 12 weeks

  • MT-8554 5mgDrug

    MT-8554 5mg QD, oral, 12 weeks

  • MT-8554 10mgDrug

    MT-8554 10mg QD, oral, 12 weeks

  • PlaceboDrug

    Placebo QD, oral, 12 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in the Average Daily Frequency of Moderate to Severe VMS at Weeks 4 and 12Time frame: Baseline, Weeks 4 and 12
  2. Change From Baseline in the Average Daily Severity Score of Mild to Severe VMS at Weeks 4 and 12Time frame: Baseline, Weeks 4 and 12

Locations

63 sites in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Birmingham, Alabama

  • Research Site

    Dothan, Alabama

  • Research Site

    Phoenix, Arizona

  • Research Site

    Norwalk, California

  • Research Site

    Sacramento, California

  • Research Site

    San Diego, California

  • Research Site

    Denver, Colorado

  • Research Site

    New London, Connecticut

  • Research Site

    New London, Connecticut

  • Research Site

    Aventura, Florida

  • Research Site

    Clearwater, Florida

  • Research Site

    Crystal River, Florida

  • Research Site

    Fort Myers, Florida

  • Research Site

    Hialeah, Florida

  • Research Site

    Hialeah, Florida

  • Research Site

    Jacksonville, Florida

  • Research Site

    Jacksonville, Florida

  • Research Site

    Jupiter, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Orlando, Florida

  • Research Site

    Orlando, Florida

  • Research Site

    Ponte Vedra, Florida

  • Research Site

    Port Saint Lucie, Florida

  • Research Site

    Sarasota, Florida

  • Research Site

    Sarasota, Florida

  • Research Site

    Wellington, Florida

  • Research Site

    West Palm Beach, Florida

  • Research Site

    Sandy Springs, Georgia

  • Research Site

    Idaho Falls, Idaho

  • Research Site

    Ankeny, Iowa

  • Research Site

    Wichita, Kansas

  • Research Site

    Marrero, Louisiana

  • Research Site

    Metairie, Louisiana

  • Research Site

    Baltimore, Maryland

  • Research Site

    Kalamazoo, Michigan

  • Research Site

    Saginaw, Michigan

  • Research Site

    Saginaw, Michigan

  • Research Site

    Kansas City, Missouri

Showing 40 of 63 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.